Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1Phase 1/2 1

Status

Unknown 4Completed 1

Sponsor Class

OTHER 39UNKNOWN 5INDUSTRY 3OTHER_GOV 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Gynecologic 1

Conditions

Esophageal Neoplasms 3Uterine Cervical Neoplasms 1Esophageal Squamous Cell Carcinoma 1

Interventions

Paclitaxel 20Capecitabine 18S 1 (combination) 17Cisplatin 15Oxaliplatin 11Radiotherapy, Intensity-Modulated 9apatinib 8Epirubicin 8Docetaxel 8Carboplatin 8Radiotherapy 7Irinotecan 7titanium silicide 6sintilimab 6pyrotinib 6nimotuzumab 6anlotinib 6Drug Therapy 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6nedaplatin 5camrelizumab 5Temozolomide 5Etoposide 5Bevacizumab 5nabiximols 4Vinorelbine 4Trastuzumab 4Radiation Dose Hypofractionation 4Radiation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
UNKNOWN × nedaplatin × Clear all
NCT02279134 2020-04-03

Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

ChineseAMS

Phase 2/3 Unknown
360 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT03603756 2020-02-11

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

ChineseAMS

Phase 2 Unknown
45 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02858206 2019-07-26

Simultaneous Integrated Boost Radiotherapy and Concurrent Nimotuzumab or Chemotherapy for Esophageal Carcinoma

ChineseAMS

Phase 2 Unknown
120 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02429622 2017-01-18

Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma

ChineseAMS

Phase 1/2 Completed
80 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01667211 2012-08-22

CSAPPPCC

ChineseAMS

Phase 2 Unknown
30 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡